Our advisory work starts from a position of respect
for our clients' organization, people,
products and science.
We have devoted our careers to the life
sciences industry and have the deepest respect
and admiration for the participants in it.
OUR TRACK RECORD
We are a very active advisor in the market.
Torreya Partners has successfully closed over
100 assignments since our founding in 2007.
We often take an operating perspective
to strategic and transaction work.
Sale of ANDAs
Sale to ANI Pharmaceuticals
Sale to Agenus
$10 million upfront in cash & stock + up to $3
June 24, 2016
Wilson Sonsini Device Conference
San Francisco, CA
June 28-30, 2016
Biotech CEO Conference Europe
July 12-14, 2016
Biotech CEO Summit
February 29, 2016
Hikma Announces the Close of the Roxane Laboratories Acquisition
February 1, 2016
ANI Pharmaceuticals Acquires Exclusive Rights to Distribute Three Generic Drug Products from H2-Pharma for $10 Million
December 23, 2015
Agenus Acquires PhosImmune with a Novel Class of Cancer Neoantigens